Clinical trial
A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing…
NCT00242268 · Alabama Neurology Associates, PC, Other · Unknown status
Key facts
| NCT number | NCT00242268 |
|---|---|
| Title | A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis |
| Lead sponsor | Alabama Neurology Associates, PC, Other |
| Collaborators | Biogen Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Relapsing Remitting Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Simvastatin |
| Enrollment | 30 |
| Start date | Oct 1, 2005 |
| First posted | Oct 20, 2005 |
| Last update posted | Dec 7, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: